Cointime update: OpenAI co-founder and president Greg Brockman said on the No Priors podcast that AI could accelerate drug discovery and help patients and doctors find relevant treatment clues buried in vast medical literature. He said some diseases lack treatments not because none exist but because research is scattered across papers that are hard to locate in time. Brockman said such capabilities could have real impact in the near term, and also cited materials science as another area where AI can improve research efficiency.
OpenAI President Brockman: AI Can Speed Drug Discovery and Match Patients to Research
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
8m ago
House Leaders Ask Nvidia CEO Jensen Huang to Brief on Megaspeed Executive Ties
13m ago
Singapore’s Symatics unveils MPU AI chip architecture
32m ago
Cipher Takes On $359M Cost Overrun at Barber Lake Data Center
37m ago
US DOJ Launches Superintelligence Task Force to Curb AI Abuse
45m ago
World Labs launches Frameboy for real-time exploration of AI-generated worlds
54m ago
Altman Says Not Holding OpenAI Equity Was His Biggest Mistake